Clinical Trials Browser

Active not recruiting × Lymphoma × duvelisib × Clear all

NCT02783625 2025-06-03

Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas

Phase 1 Active not recruiting

Lymphoma, Lymphoma, T-Cell